Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bardhan, 1991, Treatment of refractory peptic ulcer with omeprazole or continued H2-receptor antagonists: a controlled clinical trial, Gut, 32, 435, 10.1136/gut.32.4.435
Tytgat, 1987, Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists, Aliment Pharmacol Ther, 1, 31, 10.1111/j.1365-2036.1987.tb00603.x
Havu, 1986, Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion, Digestion, 35, 42, 10.1159/000199381
Havu, 1989, Partial fundectomy results in hypergastrinemia and the development of gastric ECL cell carcinoids in the rat, Scand J Gastroenterol, 24, 158, 10.3109/00365528909091272
Mattsson, 1991, Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike cell carcinoids in the rat, Gastroenterology, 100, 311, 10.1016/0016-5085(91)90197-S
Lamberts, 1993, Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis, Gastroenterology, 104, 1356, 10.1016/0016-5085(93)90344-C
Kuipers, 1996, Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication, N Engl J Med, 334, 1018, 10.1056/NEJM199604183341603
Klinkenberg, 1994, Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety, Ann Intern Med, 121, 161, 10.7326/0003-4819-121-3-199408010-00001
Lundell, 1996, Long-term results of a prospective randomized comparison of total fundic wrap (Nissen–Rosetti) or semifundoplication (Toupet) for gastroesophageal reflux, Br J Surg, 83, 830, 10.1002/bjs.1800830633
Johansson, 1993, Outcome 5 years after 360 degree fundoplication for gastroesophageal reflux disease, Br J Surg, 80, 46, 10.1002/bjs.1800800118
Sevier, 1965, Technical note: a silver method for paraffin sections of neural tissue, J Neuropathol Exp Neurol, 24, 130, 10.1097/00005072-196501000-00012
Grimelius, 1980, Silver stains in the study of endocrine cells of the gut and pancreas, Invest Cell Pathol, 3, 3
Rindi, 1986, Chromogranin A, B and C immunoreactivities of mammalian endocrine cells. Distribution, distinction from co-stored hormones/prohormones and relationship with argyrophil components of secretory granules, Histochemistry, 85, 19, 10.1007/BF00508649
Solcia, 1988, Histopathological classification of non-antral gastric endocrine growths in man, Digestion, 41, 185, 10.1159/000199786
Garvey, 1985, Modified Steiner for the demonstration of spirochetes, J Histotechnol, 1, 15, 10.1179/his.1985.8.1.15
Price, 1991, The Sydney system: histological division, J Gastroenterol Hepatol, 6, 209, 10.1111/j.1440-1746.1991.tb01468.x
Cochran, 1977, Sampling techniques, 33 and 153
Siewert, 1992, Fundoplication: how to do it? Peri-esophageal wrapping as a therapeutic principal in gastroesophageal reflux prevention, World J Surg, 16, 326, 10.1007/BF02071541
DeMeester, 1986, Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients, Ann Surg, 204, 9, 10.1097/00000658-198607000-00002
Lundell, 1998, Omeprazole or antireflux surgery in the long-term management of gastroesophageal reflux disease: results of a multicentre, randomised clinical trial, Gastroenterology, 114, A207, 10.1016/S0016-5085(98)80841-X
Lundell, 1998, Outcome of open antireflux surgery as assessed in a Nordic Multicentre Prospective Clinical Trial, Eur J Surg, 164, 751, 10.1080/110241598750005381
Siewert, 1998, What attitude should be adopted in failed antireflux procedures?, 820
Luostarinen, 1993, Nissen fundoplication for reflux esophagitis. Long-term clinical and endoscopic results in 109 of 127 consecutive patients, Ann Surg, 217, 329, 10.1097/00000658-199304000-00004
Viljakka, 1997, Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland, Scand J Gastroenterol, 32, 766, 10.3109/00365529708996532
Schnell, 1998, What is the incidence of development of Barrett's esophagus?, 933
Spechler, 1997, The columnar-lined esophagus. History, terminology and clinical issues, Gastroenterol Clin North Am, 26, 455, 10.1016/S0889-8553(05)70306-X
Welin, 1991, Triglycerides, a major coronary risk factor in elderly man. A study of men born in 1913, Eur Heart J, 12, 700
Lapidus, 1985
MONICA Project, 1987, geographic variation in mortality from cardiovascular diseases, World Health Stat Q, 40, 171
Bell, 1992, Appropriate acid suppression for the management of gastrooesophageal reflux disease, Digestion, 51, 59, 10.1159/000200917
Carlsson, 1997, Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials, Aliment Pharmacol Ther, 11, 473, 10.1046/j.1365-2036.1997.00167.x
Feldman, 1996, Relationship between severity of H. pylori infection of the antrum contributes to the development of duodenal ulcer, Gastroenterology, 110, 1386, 10.1053/gast.1996.v110.pm8613042
Ruiz, 1996, Antral atrophy, Helicobacter pylori colonization, and gastric pH, Am J Clin Pathol, 105, 96, 10.1093/ajcp/105.1.96
Kinoshita, 1997, Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese, Gut, 41, 452, 10.1136/gut.41.4.452
Schenk, 1999, Helicobacter pylori, GERD, and efficacy of omeprazole therapy for gastroesophageal reflux disease, Am J Gastroenterol, 94, 884, 10.1111/j.1572-0241.1999.982_e.x
Hattlebakk, 1997, Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole, Aliment Pharmacol Ther, 11, 1093, 10.1046/j.1365-2036.1997.00246.x
Carlsson, 1998
Kuipers, 1995, Long-term sequelae of Helicobacter pylori gastritis, Lancet, 345, 1525, 10.1016/S0140-6736(95)91084-0
Eissele, 1997, Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia, Gastroenterology, 112, 707, 10.1053/gast.1997.v112.pm9041231